122 related articles for article (PubMed ID: 3987101)
1. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
[TBL] [Abstract][Full Text] [Related]
2. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
Docci D; Turci F; Baldrati L
Nephron; 1985; 41(3):241-5. PubMed ID: 3840575
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Docci D; Turci F; Salvi P; Pretolani E
Artif Organs; 1984 May; 8(2):141-4. PubMed ID: 6547327
[TBL] [Abstract][Full Text] [Related]
4. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence for the role of secondary hyperparathyroidism in the pathogenesis of uremic thrombocytopathy.
Docci D; Turci F; Delvecchio C; Gollini C; Baldrati L; Pistocchi E
Nephron; 1986; 43(1):28-32. PubMed ID: 3754622
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Secondary hyperparathyroidism in chronic renal failure.
Malmaeus J
Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
[TBL] [Abstract][Full Text] [Related]
8. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
9. Subtotal parathyroidectomy for secondary hyperparathyroidism.
Zdon MJ; Iliopoulos JI; Thomas JH; Pierce GE; Hermreck AS; Friesen SR
Surgery; 1984 Dec; 96(6):1103-8. PubMed ID: 6505963
[TBL] [Abstract][Full Text] [Related]
10. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
[TBL] [Abstract][Full Text] [Related]
11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
12. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of time-course changes in minerals and parathyroid hormone levels during treatment with phosphate binders in hemodialysis patients with secondary hyperparathyroidism].
Yokoyama T; Onodera Y; Mano T
Clin Calcium; 2005 Sep; 15 Suppl 1():125-30; discussion 130-1. PubMed ID: 16272644
[TBL] [Abstract][Full Text] [Related]
14. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of optimal hemopurification and parathyroidectomy.
Hida M; Shimbo T; Takeda M; Saito H; Satoh T; Tajima T
Tokai J Exp Clin Med; 1983 Jul; 8(3):229-34. PubMed ID: 6670109
[TBL] [Abstract][Full Text] [Related]
15. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
16. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
17. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
18. Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism.
Cuppari L; de Carvalho AB; Avesani CM; Kamimura MA; Dos Santos Lobão RR; Draibe SA
J Am Soc Nephrol; 2004 Nov; 15(11):2933-9. PubMed ID: 15504947
[TBL] [Abstract][Full Text] [Related]
19. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
Meakins JL; Milne CA; Hollomby DJ; Goltzman D
Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
[TBL] [Abstract][Full Text] [Related]
20. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
